Evelyn Desser
Family · San Pedro, CANPI 1255459129
Payments from drug & device makers
Across 57 payments — averaging $28.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$268
- Viiv Healthcare Company$132
- Sanofi-aventis U.S. LLC$125
- Novo Nordisk$120
- Indivior Inc.$120
- Lilly USA, LLC$118
- plus $753 from 16 others
What the payments were for
- Food & beverage$1,636100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $268 |
| Viiv Healthcare Company | 4 | $132 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Novo Nordisk | 6 | $120 |
| Indivior Inc. | 4 | $120 |
| Lilly USA, LLC | 5 | $118 |
| Gilead | 4 | $109 |
| Medtronic | 1 | $108 |
| Exact Sciences | 3 | $77 |
| Braeburn Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $54 |
| Amgen | 2 | $51 |
| Hologic Sales And Service, LLC | 2 | $49 |
| Alkermes, Inc. | 2 | $45 |
| Madrigal Pharmaceuticals | 1 | $40 |
| Dexcom, Inc. | 1 | $28 |
| Sanofi Pasteur Inc. | 1 | $26 |
| GSK | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Abbott | 1 | $21 |
| Seqirus USA Inc | 1 | $21 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$108
How this compares
$1,636 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 46 | $62,093 |
| TrulicityDulaglutide | 37 | $37,236 |
| MounjaroTirzepatide | 21 | $21,242 |
| OzempicSemaglutide | 22 | $19,372 |
| Bydureon BciseExenatide Microspheres | 12 | $9,757 |
| Varenicline Tartrate | 12 | $5,995 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $5,878 |
| Bupropion XlBupropion Hcl | 12 | $3,959 |
| Advair DiskusFluticasone Propion/Salmeterol | 11 | $1,522 |
| Atorvastatin Calcium | 157 | $1,130 |
| Pioglitazone Hcl | 47 | $713 |
| Lisinopril | 82 | $664 |
| Ventolin HfaAlbuterol Sulfate | 11 | $615 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $558 |
| Levothyroxine Sodium | 36 | $533 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $118 | $58,47858 claims |
| Novo NordiskOzempic | $120 | $19,37222 claims |
| GSKBreo Ellipta | $25 | $5,87816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,634 family providers in California.
Other family in San Pedro
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.